Status:
RECRUITING
Assessment of Revascularization in Plantar Foot of Diabetic Patients Pre and Post Angioplasty Using Spatial Frequency Domain Imaging
Lead Sponsor:
Singapore General Hospital
Conditions:
Peripheral Arterial Disease(PAD)
Imaging Evaluation
Eligibility:
All Genders
21-99 years
Phase:
NA
Brief Summary
To explore the usefulness of SFDI in the assessment of revascularization pre and post intervention
Detailed Description
Diabetes is a chronic disease with high cardiovascular morbidity and mortality ((Matheus et al., 2013)). Approximately 150 million worldwide are suffering from this condition and the number is expecte...
Eligibility Criteria
Inclusion Criteria:
- Patients of age 21 years and above with diabetes and undergoing lower limb arterial angioplasty
- Willingness to participate in the study and undergo foot physiological assessments using SFDI
Exclusion Criteria:
- Mentally incompetent, younger than 21 years of age, prisoners, pregnant or breastfeeding women
- Patients unable to provide informed consent
- Any medical condition which makes the candidate an inappropriate subject for study participation, in the investigator's judgment
Key Trial Info
Start Date :
October 2 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2025
Estimated Enrollment :
15 Patients enrolled
Trial Details
Trial ID
NCT07097857
Start Date
October 2 2024
End Date
December 1 2025
Last Update
July 31 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Singapore General Hospital
Singapore, SG, Singapore, 169856